Hypovolaemia Due to Acute Blood Loss

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hypovolaemia Due to Acute Blood Loss trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 4

NCT03278548

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elect…

The aim of the study is to investigate the safety of a 6% HES (Hydroxyethyl Starch) solution (Volulyte 6%) versus an electrolyte solution (Ionolyte) in patients…

Austria, Belgium2,289 participantsStarted 2017-09-28

Treatment: Volulyte 6%, Ionolyte

CompletedPhase 4

NCT03338218

Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients

The aim of the study is to investigate the safety of a 6% hydroxyethyl starch (HES) solution (Volulyte 6%) versus an electrolyte solution (Ionolyte) in trauma p…

Belgium, Czechia, France238 participantsStarted 2019-02-23

Treatment: Volulyte 6%, Ionolyte